Zivo Bioscience Performance
| ZIVODelisted Stock | USD 1.81 0.01 0.55% |
The firm maintains a market beta of -0.63, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Zivo Bioscience are expected to decrease at a much lower rate. During the bear market, Zivo Bioscience is likely to outperform the market. Zivo Bioscience right now maintains a risk of 0.0%. Please check out Zivo Bioscience treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Zivo Bioscience will be following its historical returns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Zivo Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Zivo Bioscience is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 8.9 M | |
| Free Cash Flow | -7.1 M |
Zivo |
Zivo Bioscience Relative Risk vs. Return Landscape
If you would invest 181.00 in Zivo Bioscience on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Zivo Bioscience or generate 0.0% return on investment over 90 days. Zivo Bioscience is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Zivo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Zivo Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zivo Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zivo Bioscience, and traders can use it to determine the average amount a Zivo Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ZIVO |
Based on monthly moving average Zivo Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zivo Bioscience by adding Zivo Bioscience to a well-diversified portfolio.
Zivo Bioscience Fundamentals Growth
Zivo Stock prices reflect investors' perceptions of the future prospects and financial health of Zivo Bioscience, and Zivo Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zivo Stock performance.
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 | ||||
| Operating Margin | (133.25) % | ||||
| Current Valuation | 2.02 M | ||||
| Shares Outstanding | 1.82 M | ||||
| Price To Earning | (1.95) X | ||||
| Price To Book | 17.86 X | ||||
| Price To Sales | 2,639 X | ||||
| EBITDA | (8.73 M) | ||||
| Cash And Equivalents | 5.08 M | ||||
| Cash Per Share | 0.54 X | ||||
| Total Debt | 445.18 K | ||||
| Debt To Equity | 0.28 % | ||||
| Book Value Per Share | (0.63) X | ||||
| Cash Flow From Operations | (7.1 M) | ||||
| Earnings Per Share | (5.33) X | ||||
| Total Asset | 2.12 M | ||||
| Retained Earnings | (115.8 M) | ||||
| Current Asset | 28.93 K | ||||
| Current Liabilities | 4.97 M | ||||
About Zivo Bioscience Performance
By examining Zivo Bioscience's fundamental ratios, stakeholders can obtain critical insights into Zivo Bioscience's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Zivo Bioscience is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan. Zivo Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.Things to note about Zivo Bioscience performance evaluation
Checking the ongoing alerts about Zivo Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zivo Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zivo Bioscience is not yet fully synchronised with the market data | |
| Zivo Bioscience may become a speculative penny stock | |
| Zivo Bioscience has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.75 M) with profit before overhead, payroll, taxes, and interest of 20 K. | |
| Zivo Bioscience currently holds about 5.08 M in cash with (7.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54. | |
| Roughly 25.0% of the company outstanding shares are owned by insiders |
- Analyzing Zivo Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zivo Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Zivo Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zivo Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zivo Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zivo Bioscience's stock. These opinions can provide insight into Zivo Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |